 than those observed in clinical trials that use 30-day event rates and mandatory
postprocedure
evaluations
by
an
independent
neurologist.
Timing of CEA. Increasing evidence has shown that
CEA provides maximum beneÔ¨Åt if performed
in <14 days for patients presenting with TIA or amaurosis
fugax.17 Natural history studies reported that the incidence of recurrent symptoms after the index TIA ranges
from 5% to